Experience

PlantForm Corporation

• Canada
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• CEO

  • Apr 2008 - Present

  PlantForm Corporation, a Canada Top10 Lifesciences winner, is focused on providing low cost therapeutic drugs for the improvement of quality of life. The Company uses proprietary technology licensed from the University of Guelph to manufacture low cost antibody drugs in plants. PlantForm Corporation, a Canada Top10 Lifesciences winner, is focused on providing low cost therapeutic drugs for the improvement of quality of life. The Company uses proprietary technology licensed from the University of Guelph to manufacture low cost antibody drugs in plants.



AntoXa Corporation

• Canada
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• CEO

  • Aug 2016 - Present

  AntoXa Corporation focuses on developing, manufacturing and commercializing innovative drugs for defense applications. The range of chemical and biological threats is wide and varies from naturally occurring threats such as Ricin to man-made threats such as Sarin gas. According to Bill Gates, “Bioterrorism is a much larger risk than a pandemic”. AntoXa Corporation focuses on developing, manufacturing and commercializing innovative drugs for defense applications. The range of chemical and biological threats is wide and varies from naturally occurring threats such as Ricin to man-made threats such as Sarin gas. According to Bill Gates, “Bioterrorism is a much larger risk than a pandemic”.



Alba Biologics Group

• Biotechnology Research
• 1 - 100 Employee

• President

  • Oct 2007 - Present

  Alba Biologics Group is a leading biopharmaceutical strategic and technical support group providing consulting and management services to start-ups, early product developers and established industry leaders. With 20 years experience Alba Biologics leverages the expertise of the founder and our associates to help clients advance drug candidates from the bench through to regulatory approval. Alba will support client organizations on both short and long term projects working with a client’s in house staff as well as integrating with contract service providers. Show less



Cangene Corporation

• Director Research and Development

  • Aug 1985 - Oct 2007

  Don Stewart was the Director Research for Cangene Corporation with 20 years experience in the Biotechnology industry and a background in basic research. Dr. Stewart was responsible for research and development of monoclonal antibodies, polyclonal antibodies and recombinant protein drugs, projects that are conducted both in house at Cangene and at contract sites. In addition Dr. Stewart was responsible for the companies preclinical toxicology department.Dr. Stewart studied Biochemistry and Cell Biology and as a Medical Research Council scholar graduated with a PhD in 1982 from the University of London, England. Additional laboratory research experience was obtained as an Alberta Heritage Foundation for Medical Research post-doctoral scholar in the MRC Protein Structure- Function Group at the University of Alberta from 1982 to 1985. Show less

• Director R&D

  • 1985 - 2007



University of Alberta

• Canada
• Higher Education
• 700 & Above Employee

• Post Doctoral Fellow

  • Jan 1982 - Aug 1985